Weicong Wang

1.4k total citations · 1 hit paper
20 papers, 1.2k citations indexed

About

Weicong Wang is a scholar working on Renewable Energy, Sustainability and the Environment, Materials Chemistry and Molecular Biology. According to data from OpenAlex, Weicong Wang has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Renewable Energy, Sustainability and the Environment, 7 papers in Materials Chemistry and 6 papers in Molecular Biology. Recurrent topics in Weicong Wang's work include Electrocatalysts for Energy Conversion (10 papers), Advanced Memory and Neural Computing (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Weicong Wang is often cited by papers focused on Electrocatalysts for Energy Conversion (10 papers), Advanced Memory and Neural Computing (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Weicong Wang collaborates with scholars based in China, United States and Switzerland. Weicong Wang's co-authors include Mingshang Jin, Tianou He, Xiaolong Yang, Yadong Yin, Xiang Li, Fenglei Shi, Jianbo Wu, Yaming Liu, Zhiwei Shan and Zhao Wang and has published in prestigious journals such as Nature, Nature Communications and Nano Letters.

In The Last Decade

Weicong Wang

19 papers receiving 1.2k citations

Hit Papers

Mastering the surface strain of platinum catalysts for ef... 2021 2026 2022 2024 2021 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weicong Wang China 14 821 503 501 131 103 20 1.2k
Lu Bai China 17 487 0.6× 453 0.9× 452 0.9× 138 1.1× 61 0.6× 37 993
Qiheng Li China 10 866 1.1× 600 1.2× 411 0.8× 104 0.8× 57 0.6× 23 1.1k
Jingxuan Ge China 12 683 0.8× 456 0.9× 510 1.0× 55 0.4× 61 0.6× 28 1.1k
Yucheng Zhu China 22 198 0.2× 240 0.5× 621 1.2× 135 1.0× 22 0.2× 76 1.3k
Andrei Ştefancu Romania 24 405 0.5× 199 0.4× 374 0.7× 35 0.3× 71 0.7× 42 1.4k
Zongyang Qiu China 10 371 0.5× 160 0.3× 313 0.6× 60 0.5× 23 0.2× 15 988
Yuchen Zhu China 18 329 0.4× 249 0.5× 383 0.8× 270 2.1× 31 0.3× 38 992
Feiyang Geng China 11 193 0.2× 191 0.4× 180 0.4× 50 0.4× 32 0.3× 23 520

Countries citing papers authored by Weicong Wang

Since Specialization
Citations

This map shows the geographic impact of Weicong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weicong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weicong Wang more than expected).

Fields of papers citing papers by Weicong Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weicong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weicong Wang. The network helps show where Weicong Wang may publish in the future.

Co-authorship network of co-authors of Weicong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Weicong Wang. A scholar is included among the top collaborators of Weicong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weicong Wang. Weicong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Shuya, Cuicui Yang, Weicong Wang, et al.. (2024). First-in-human study to assess the safety, tolerability, and pharmacokinetics of intravenous SHPL-49 following single- and multiple-ascending-dose administration in healthy adults. Journal of Pharmaceutical and Biomedical Analysis. 249. 116314–116314. 2 indexed citations
2.
Zheng, Yangzi, Jiapeng Huang, Ruiyun Guo, et al.. (2024). Palladium phosphide interlayer sandwiched into Pd nanocrystals for enhanced formic acid electrooxidation reaction performance. Chemical Engineering Journal. 503. 158685–158685. 5 indexed citations
3.
Zheng, Yangzi, Ruiyun Guo, Xiang Li, et al.. (2023). Synthesis of amorphous trimetallic PdCuNiP nanoparticles for enhanced OER. Frontiers in Chemistry. 11. 1122333–1122333. 4 indexed citations
4.
Wang, Weicong, Tianou He, Zhaorui Zhang, et al.. (2022). Tailoring Amorphous PdCu Nanostructures for Efficient C–C Cleavage in Ethanol Electrooxidation. Nano Letters. 22(17). 7028–7033. 40 indexed citations
5.
Zhang, Ke, Yucheng He, Ruiyun Guo, et al.. (2022). Interstitial Carbon-Doped PdMo Bimetallene for High-Performance Oxygen Reduction Reaction. ACS Energy Letters. 7(10). 3329–3336. 54 indexed citations
6.
He, Tianou, Weicong Wang, Fenglei Shi, et al.. (2021). Mastering the surface strain of platinum catalysts for efficient electrocatalysis. Nature. 598(7879). 76–81. 447 indexed citations breakdown →
7.
Wang, Weicong, Tianou He, Xiaolong Yang, et al.. (2021). General Synthesis of Amorphous PdM (M = Cu, Fe, Co, Ni) Alloy Nanowires for Boosting HCOOH Dehydrogenation. Nano Letters. 21(8). 3458–3464. 82 indexed citations
8.
He, Tianou, Weicong Wang, Xiaolong Yang, et al.. (2021). Deposition of Atomically Thin Pt Shells on Amorphous Palladium Phosphide Cores for Enhancing the Electrocatalytic Durability. ACS Nano. 15(4). 7348–7356. 74 indexed citations
10.
Li, Xiang, Yaming Liu, Wei Bi, et al.. (2020). Lattice-mismatch-induced growth of ultrathin Pt shells with high-index facets for boosting oxygen reduction catalysis. Journal of Materials Chemistry A. 8(32). 16477–16486. 26 indexed citations
11.
Wang, Weicong, Xiang Li, Tianou He, Yaming Liu, & Mingshang Jin. (2019). Engineering Surface Structure of Pt Nanoshells on Pd Nanocubes to Preferentially Expose Active Surfaces for ORR by Manipulating the Growth Kinetics. Nano Letters. 19(3). 1743–1748. 70 indexed citations
12.
Zheng, Xin Xiao, Weicong Wang, Yanbao Zhang, et al.. (2019). Development of an LC–MS/MS method for quantifying two main metabolites of abivertinib in human plasma. Biomedical Chromatography. 34(2). e4704–e4704. 3 indexed citations
13.
Liu, Yaming, Chaoqi Wang, Weicong Wang, et al.. (2019). H2-Induced coalescence of Pt nanoparticles for the preparation of ultrathin Pt nanowires with high-density planar defects. Nanoscale. 11(31). 14828–14835. 29 indexed citations
14.
Wang, Chao, Peiyu Zhang, Tianhong Zhang, et al.. (2018). Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. Journal of Medicinal Chemistry. 61(5). 2018–2026. 40 indexed citations
15.
Wang, Chao, Tianhong Zhang, Ruiyuan Cao, et al.. (2018). De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery. Journal of Medicinal Chemistry. 61(19). 8734–8745. 46 indexed citations
16.
Ma, Yuxiang, Xin Xiao Zheng, Hongyun Zhao, et al.. (2018). First-in-Human Phase I Study of AC0010, a Mutant-Selective EGFR Inhibitor in Non–Small Cell Lung Cancer: Safety, Efficacy, and Potential Mechanism of Resistance. Journal of Thoracic Oncology. 13(7). 968–977. 49 indexed citations
17.
Yuan, Baoshi, et al.. (2018). Bioavailability of Edaravone Sublingual Tablet Versus Intravenous Infusion in Healthy Male Volunteers. Clinical Therapeutics. 40(10). 1683–1691. 16 indexed citations
18.
Wang, Lu, Xin Xiao Zheng, Weicong Wang, Pei Hu, & Ji Jiang. (2017). An LC–MS/MS method for quantification of AC0010, a novel mutant-selective epidermal growth factor receptor (EGFR) inhibitor, and its metabolites in human plasma and the application to a pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis. 141. 9–18. 4 indexed citations
20.
He, Tianou, Weicong Wang, Xiaolong Yang, et al.. (2017). Inflating hollow nanocrystals through a repeated Kirkendall cavitation process. Nature Communications. 8(1). 1261–1261. 168 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026